M3, Inc.
Q1 of Fiscal Year 2027 Financial Summary [IFRS] (Consolidated)
Consolidated revenue for Q1 FY2027 reached 90,105 million yen (YoY +4.5%), operating income 18,077 million yen (△8.6%), and net income attributable to owners of parent 10,579 million yen (△21.8%). Segment-wise, Medical Platform and International segments were solid, but profitability worsened notably in Site Solutions. Full-year guidance is currently undetermined.
Key Figures
- Revenue: 90,105 million yen (YoY +4.5%)
- Operating income: 18,077 million yen (YoY -8.6%)
- Net income: 10,579 million yen (YoY -21.8%)
AI要約
Performance overview
Consolidated revenue for the quarter increased 4.5% year over year to 90,105 million yen. Operating income declined 8.6% year over year to 18,077 million yen, and pre-tax income fell 5.3% year over year to 18,641 million yen, with net income decreasing 21.8% year over year to 10,579 million yen. By segment, Medical Platform and International were solid, while profitability deteriorated notably in Site Solutions. The impact of new subsidiaries and ongoing pre-investments likely weighed on profits.
Outlook and dividends
Full-year earnings guidance remains undetermined per the disclosed assumptions. The company plans to determine the dividend level taking into account capital needs and cash flow conditions. An accompanying earnings presentation is expected to be released, with further details on management performance to be disclosed in due course.
M3, Inc.
Company overview · Stock price · Financial data · All IR
